LONDON, May 20 (Reuters) – New global guidelines on the
treatment of heart failure endorse the use of Novartis’
Entresto, boosting the prospects for a drug that has struggled
to gain traction since…
The post New medical guidelines back use of Novartis heart failure drug appeared first on NASDAQ.